Organisation profile
Organisation profile
Research Mission
The Prof. De Nicolo group at Riga Stradiņš University (RSU) is committed to advancing knowledge of genetic susceptibility to cancer (primarily, breast and ovarian cancer) so that informed clinical choices can be made. By building and consolidating synergies across disciplines and through an ever-expanding solid network of international collaborations, the group tackles matters that extend beyond cancer genetics to translational and clinical oncology, epidemiology, and public health.
Focus Areas
- Standardized data collection, curation, and federated analysis
- Interpretation, communication, and clinical application of germline genetic test results (emphasis on BRCA1 and BRCA2 genes and their so-called ‘variants of uncertain significance’, VUS) [Clinical Working Group Chair, ENIGMA]
- Reduced penetrance variants in breast/ovarian cancer genes (identification, refinement of associated cancer risk, and clinical management of carrier individuals) [Clinical Working Group Chair, ENIGMA]
- Genotype-phenotype relationships
- Education and training of health care professionals; cancer patients’ and citizens’ literacy on matters related to genetic susceptibility to cancer (identification of knowldge gaps and development of tailored educational initiatives) [EU-funded Joint Action on Personalized Cancer Medicine (Subtask Lead); Italian National Institute of Health]
- Equity issues in the use of genetic testing and access to translational oncology [Clinical Working Group Chair, ENIGMA]
Methodology
Electronic surveys, observational (case-control, cohort) studies, federated analysis, bioinformatic analyses
Expanded Scope
Fostering multidisciplinary breast/ovarian cancer research to contribute to precision cancer prevention and care, and improved outcomes.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Arcangela De Nicolo
- Institute of Oncology and Molecular Genetics, Prof. Arcangela De Nicolo Group. Genetic susceptibility to breast cancer - Research Professor (Tenured Professor)
Person
Projects
- 1 Active
-
JA PCM: Joint Action Personalised Cancer Medicine
Irmejs, A. (Partner's coordinator), Čakstiņa-Dzērve, I. (Work package leader) & De Nicolo, A. (Work package leader)
1/11/25 → 31/10/29
Project: EU Programmes › Other
-
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
Zanti, M., O'Mahony, D. G., Parsons, M. T., De Nicolo, A., Michailidou, K. (Corresponding Author), Dorling, L., Dennis, J., Boddicker, N. J., Chen, W., Hu, C., Naven, M., Yiangou, K., Ahearn, T. U., Ambrosone, C. B., Andrulis, I. L., Antoniou, A. C., Auer, P. L., Baynes, C., Bodelon, C. & Bogdanova, N. V. & 31 others, , Dec 2025, In: Nature Communications. 16, 1, p. 1-18 18 p., 4852.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)6 Downloads (Pure) -
Exploring Literacy and Knowledge Gaps and Disparities in Genetics and Oncogenomics Among Cancer Patients and the General Population: A Scoping Review
Nikitara, K. (Corresponding Author), Cardoso, M. L., Vicente, A. M., Batalha Silva Rasga, C. M., De Angelis, R., Chamoun Morel, Z., De Nicolo, A., Nomikou, M., Karamanidou, C. & Kakalou, C., 9 Jan 2025, In: Healthcare (Switzerland). 13, 2, 16 p., 121.Research output: Contribution to journal › Review article › peer-review
Open AccessFile5 Downloads (Pure)
Activities
-
Genetic testing for breast cancer susceptibility as a cornerstone of precision medicine
De Nicolo, A. (Speaker)
12 Mar 2026Activity: Talk or presentation types › Oral presentation
-
Kick-off Meeting of the Joint Action Personalized Cancer Medicine
De Nicolo, A. (Participant)
14 Jan 2026 → 15 Jan 2026Activity: Participating in or organising an event types › Participating in a conference, workshop, ...
-
Varianti germinali di DICER1 e fenotipi (neoplastici e non) associati [Germline DICER1 variants and associated, neoplastic and non, phenotypes]
De Nicolo, A. (Invited speaker)
24 Sept 2025Activity: Talk or presentation types › Invited talk